Breast Neoplasms: all 12,820 studies
Page 108 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer PatientsStatus unknownNCT01210768Phase 2
- Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast CancerCompletedNCT01208779
- Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast CancerCompletedNCT01208480Phase 2
- RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast CancerTerminatedNCT01208441Phase 1
- Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast CancerCompletedNCT01207635
- Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast CancerCompletedNCT01206881Phase 2
- Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast CancerWithdrawnNCT01205217Phase 2
- Brown Seaweed as a Breast Cancer PreventiveCompletedNCT01204957Phase 1/2
- Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer TumorsStatus unknownNCT01204801Phase 3
- Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the BreastCompletedNCT01204437Phase 2/3
- IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:CompletedNCT01204242Phase 2
- Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer PatientsCompletedNCT01204125Phase 2
- Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast CancerActive, not recruitingNCT01203839Phase 2
- Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast CancerCompletedNCT01203267Phase 2
- Relaxation for Women With Breast Cancer Undergoing RadiotherapyActive, not recruitingNCT01202851Phase 3
- A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast CancerTerminatedNCT01200212Phase 3
- Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast CancerCompletedNCT01199432Phase 4
- Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast CancerCompletedNCT01199393
- Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast CancerTerminatedNCT01199367Phase 1
- Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC)Status unknownNCT01199354Phase 2
- Study to Investigate Adherence of Patients to Clodronate (Bonefos) TreatmentCompletedNCT01198457
- Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to ChemotherapyCompletedNCT01198301
- Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast CancerStatus unknownNCT01196455Phase 2
- Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast CancerStatus unknownNCT01195298Phase 2
- PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)CompletedNCT01192308Phase 1
- Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast CancerStatus unknownNCT01191164Not applicable
- Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast CancerCompletedNCT01190982Phase 2
- Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast CancerCompletedNCT01190345Phase 2
- Intraoperative Radiotherapy for Early Stage Breast CancerCompletedNCT01189851Not applicable
- Personalised Program for Women Treated for Hodgkin DiseaseTerminatedNCT01188915Not applicable
- Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast CancerCompletedNCT01186991Phase 2
- Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated RadiotherapyStatus unknownNCT01185145Phase 2
- The Attitudes, Communication, Treatment and Support Intervention to Reduce Breast Cancer Treatment DisparityCompletedNCT01184066Not applicable
- Radiotherapy - Anastrazole Concomitant : Evaluation of the Side EffectsCompletedNCT01183832
- Lung Inflammation and Lung Metastases From Breast CancerCompletedNCT01182519
- Rehabilitation of Cognitive Changes in Breast Cancer SurvivorsActive, not recruitingNCT01182506Not applicable
- Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast CancerCompletedNCT01180335Phase 3
- Early Detection of Cancers in Low Resource CountriesStatus unknownNCT01178736
- Mindfulness-Based Stress Reduction (MBSR) Symptom Cluster Trial for Breast Cancer SurvivorsCompletedNCT01177124Not applicable
- A 5 Year Follow-up on Newly Diagnosed Breast Cancer PatientsTerminatedNCT01176838
- Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast TumorStatus unknownNCT01176799Phase 2
- Study of Apatinib in Metastatic Triple-Negative Breast Cancer PatientsCompletedNCT01176669Phase 2
- Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast CancerStatus unknownNCT01175694Phase 2
- A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisCompletedNCT01173497Phase 2
- Metabolic Syndrome as Modifiable Risk Factor for Breast CancerStatus unknownNCT01172886
- Primary Chemotherapy in Patients With HER2-positive Early Breast CancerCompletedNCT01172223Phase 1/2
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- Circadian Disturbances After Breast Cancer SurgeryCompletedNCT01171508
- A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast CancerCompletedNCT01171417
- Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast CancerStatus unknownNCT01170143Phase 2
- Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer PatientsWithdrawnNCT01169870Phase 2
- Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer PatientsCompletedNCT01169792
- Iron Supplement in the Prevention of Anemia in Female Breast Cancer PatientsStatus unknownNCT01168505Phase 2
- BCRL Prevention PilotCompletedNCT01166672
- Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy RatesTerminatedNCT01166581
- Impact of Acceptance and Commitment Therapy on Early Stage Breast CancerCompletedNCT01164930Not applicable
- A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast CancerWithdrawnNCT01163929Phase 2
- Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast CancerCompletedNCT01162200Phase 1
- A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer PatientsTerminatedNCT01161368Phase 2
- Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor TherapyCompletedNCT01160718Phase 2
- The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast CancerStatus unknownNCT01159405Phase 1
- Molecular Triaging of Newly Diagnosed Breast CancerWithdrawnNCT01159236Not applicable
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
- Exercise Program of Breast Cancer Patients Undergoing Chemotherapy With or Without RadiationCompletedNCT01157767
- Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise LaboratoryStatus unknownNCT01157130Not applicable
- A Pilot Clinical Trial With Tocotrienol on Breast CancerCompletedNCT01157026Not applicable
- A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)WithdrawnNCT01156961Phase 4
- A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast CancerCompletedNCT01156753Phase 2
- Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With BevacizumabCompletedNCT01156168
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Preoperative Localisation of the Sentinel Lymph Node in Breast CancerCompletedNCT01154972Not applicable
- Physical Functional Side Effects of Taxane Chemotherapy for Breast CancerCompletedNCT01153282
- Moderating the Negative Impact of Abnormal Screening MammogramsCompletedNCT01153126Not applicable
- Excision Followed by Radiofrequency Ablation for Breast CancerActive, not recruitingNCT01153035Not applicable
- A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinCompletedNCT01152606
- A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant TherapyCompletedNCT01152398Phase 1
- Nutrition, Exercise, and Breast Cancer SurvivorshipCompletedNCT01151488Not applicable
- Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast CancerCompletedNCT01150513Phase 2/3
- A Combination of Abraxane and Cisplatin in Metastatic Breast CancerCompletedNCT01149798Phase 2
- RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerTerminatedNCT01149356Phase 1
- Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast CancerCompletedNCT01148875
- Safety Study of MGAH22 in HER2-positive CarcinomasCompletedNCT01148849Phase 1
- A Study of Foretinib in Patients With Recurrent/Metastatic Breast CancerCompletedNCT01147484Phase 2
- Physical Activity, Fatigue, Sleep, and InflammationCompletedNCT01147367Not applicable
- Axillary Reverse Mapping for Breast CarcinomasCompletedNCT01146158Phase 3
- Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast CancerCompletedNCT01145430Phase 1
- Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) TreatmentCompletedNCT01144572
- Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone MetastasesCompletedNCT01144481
- A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast CancerCompletedNCT01142778Phase 2
- Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With RadiotherapyCompletedNCT01142479Phase 2/3
- Manual Therapy in Postoperative Breast CancerCompletedNCT01142141Not applicable
- Evaluating an Internet-based Intervention for Insomnia in Breast Cancer SurvivorsWithdrawnNCT01141868Not applicable
- Deep Sequencing of the Breast Cancer TranscriptomeWithdrawnNCT01141530
- Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant TherapyTerminatedNCT01140776
- Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast CancerStatus unknownNCT01140763
- Exercise Program for Early Breast Cancer SurvivorsCompletedNCT01140282Not applicable
- Incidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerCompletedNCT01139957
- Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast CancerTerminatedNCT01138553Early Phase 1
- Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast CancerCompletedNCT01138384Phase 1/2
- Biomarkers in Blood Samples From Older Breast Cancer SurvivorsCompletedNCT01138345